Published on 20 Sep 2023 on Simply Wall St. via Yahoo Finance
Institutional investors may adopt severe steps after Poseida Therapeutics, Inc.'s (NASDAQ:PSTX)...
Key Insights
Significantly high institutional ownership implies Poseida Therapeutics' stock price is sensitive to their trading actionsThe top 6 shareholders own 54% of the companyOwnership research along with analyst forecasts data help provide a good understanding of opportunities in a stock
If you want to know who really controls Poseida Therapeutics, Inc. (NASDAQ:PSTX), then you'll have to look at the makeup of its share registry. With 44% stake, institutions possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk).